Amneal Pharmaceuticals, Inc.Amneal Pharmaceuticals, Inc.Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.05 B‬USD
−0.56USD
‪−83.99 M‬USD
‪2.39 B‬USD
‪111.14 M‬
Beta (1Y)
0.66

About Amneal Pharmaceuticals, Inc.

Headquarters
Bridgewater
Employees (FY)
‪7.85 K‬
Website
Founded
2002
FIGI
BBG00462PGG0
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AMRX is 6.65 USD — it has decreased by 1.48% in the past 24 hours. Watch Amneal Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Amneal Pharmaceuticals, Inc. stocks are traded under the ticker AMRX.
AMRX stock has fallen by 4.04% compared to the previous week, the month change is a 0.45% fall, over the last year Amneal Pharmaceuticals, Inc. has showed a 126.19% increase.
We've gathered analysts' opinions on Amneal Pharmaceuticals, Inc. future price: according to them, AMRX price has a max estimate of 9.00 USD and a min estimate of 8.00 USD. Watch AMRX chart and read a more detailed Amneal Pharmaceuticals, Inc. stock forecast: see what analysts think of Amneal Pharmaceuticals, Inc. and suggest that you do with its stocks.
AMRX reached its all-time high on Apr 9, 2015 with the price of 52.10 USD, and its all-time low was 0.81 USD and was reached on Oct 22, 1998. View more price dynamics on AMRX chart.
See other stocks reaching their highest and lowest prices.
AMRX stock is 4.30% volatile and has beta coefficient of 0.66. Track Amneal Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Amneal Pharmaceuticals, Inc. there?
Today Amneal Pharmaceuticals, Inc. has the market capitalization of ‪2.05 B‬, it has increased by 3.70% over the last week.
Yes, you can track Amneal Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Amneal Pharmaceuticals, Inc. is going to release the next earnings report on Aug 5, 2024. Keep track of upcoming events with our Earnings Calendar.
AMRX earnings for the last quarter are 0.14 USD per share, whereas the estimation was 0.09 USD resulting in a 52.07% surprise. The estimated earnings for the next quarter are 0.14 USD per share. See more details about Amneal Pharmaceuticals, Inc. earnings.
Amneal Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪659.19 M‬ USD, despite the estimated figure of ‪619.00 M‬ USD. In the next quarter, revenue is expected to reach ‪664.45 M‬ USD.
AMRX net income for the last quarter is ‪−91.64 M‬ USD, while the quarter before that showed ‪−98.65 M‬ USD of net income which accounts for 7.10% change. Track more Amneal Pharmaceuticals, Inc. financial stats to get the full picture.
No, AMRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 23, 2024, the company has ‪7.85 K‬ employees. See our rating of the largest employees — is Amneal Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Amneal Pharmaceuticals, Inc. EBITDA is ‪537.60 M‬ USD, and current EBITDA margin is 20.57%. See more stats in Amneal Pharmaceuticals, Inc. financial statements.
Like other stocks, AMRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amneal Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amneal Pharmaceuticals, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amneal Pharmaceuticals, Inc. stock shows the neutral signal. See more of Amneal Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.